English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17933/22952 (78%)
Visitors : 7314996      Online Users : 549
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24908


    Title: Selective Activation of ZAK beta Expression by 3-Hydroxy-2-Phenylchromone Inhibits Human Osteosarcoma Cells and Triggers Apoptosis via JNK Activation
    Authors: Fu, CY;Lay, IS;Shibu, MA;Tseng, YS;Kuo, WW;Yang, JJ;Wang, TF;Mahalakshmi, B;Yeh, YL;Huang, CY
    Keywords: osteosarcoma;3-Hydroxy-2-phenylchromone;ZAK beta;apoptosis
    Date: 2020
    Issue Date: 2022-08-09T08:09:57Z (UTC)
    Publisher: MDPI
    Abstract: Although various advancements in radical surgery and neoadjuvant chemotherapy have been developed in treating osteosarcoma (OS), their clinical prognosis remains poor. A synthetic chemical compound, 3-hydroxylflavone, that is reported to regulate ROS production is known to inhibit human bone osteosarcoma cells. However, its role and mechanism in human OS cells remains unclear. In this study, we have determined the potential of 3-Hydroxy-2-phenylchromone (3-HF) against OS using human osteosarcoma (HOS) cells. Our previous studies showed that Zipper sterile-alpha-motif kinase (ZAK), a kinase member of the MAP3K family, was involved in various cellular events such as cell proliferation and cell apoptosis, and encoded two transcriptional variants, ZAK alpha and beta. In this study, we show that 3-HF induces the expression of ZAK and thereby enhances cellular apoptosis. Using gain of function and loss of function studies, we have demonstrated that ZAK activation by 3-HF in OS cells is confined to a ZAK beta form that presumably plays a leading role in triggering ZAK alpha expression, resulting in an aggravated cancer apoptosis. Our results also validate ZAK beta as the predominant form of ZAK to drive the anticancer mechanism in HOS cells.
    URI: http://dx.doi.org/10.3390/ijms21093366
    https://www.webofscience.com/wos/woscc/full-record/WOS:000535581700337
    https://ir.csmu.edu.tw:8080/handle/310902500/24908
    Relation: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ,2020 ,v21 ,issue 9
    Appears in Collections:[中山醫學大學研究成果] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML210View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback